BioSpace News Archive

Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on developing lenzilumab (LENZ®), a first-in class antibody that neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), today reported financial results for the third quarter and nine months ended September 30, 2022.

Rockley Photonics Holdings Limited, a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, announced that it will participate in the following investor conferences.

Humanetics Corporation (Humanetics) announced the publication of results from their recently completed phase 1 trial of BIO 300 Oral Powder in healthy volunteers in the journal Clinical Pharmacology in Drug Development (NCT04650555).

Riverain Technologies, the pioneer of Clear Visual Intelligence™ for chest imaging interpretation, was selected by the Veterans Health Administration to provide its unique imaging interpretation solution, ClearRead™ CT, to the Veteran Affair’s Lung Precision Oncology Program.

Pharmaceutics International, Inc., a contract development and manufacturing organization has been promoted Devan Patel to Vice President – Client Services, where he will oversee Pii’s Business Operations & Program Management functions.

Cytek Biosciences, Inc. announced the launch of Cytek Cloud – a cloud-based platform that features two integrated tools to streamline workflows on Cytek’s state-of-the-art cell sorters and analyzers.

Intelivation Technologies, a medical device company with a cutting-edge orthopedic portfolio announced today the launch of the Inlet Foot Plating System™.

Proscia®, a leading provider of digital and computational pathology solutions, today announced new research on improving the generalization of an artificial intelligence (AI) classification model with contrastive self-supervised learning.

Today, the U.S. Food and Drug Administration issued a Federal Register notice, Safety and Effectiveness of Certain Naloxone Hydrochloride Drug Products for Nonprescription Use, that may help facilitate the development and approval of certain nonprescription naloxone drug products, including through the switch of certain naloxone drug products from prescription status to nonprescription status.

As a cutting-edge rehabilitation solution provider, after first appearing at MEDICA 2021, Siyi Intelligence once again presented its SYREBO® soft robotic hand rehabilitation gloves and launched the new generation HRC12 robotic rehab glove for home use at MEDICA 2022 (Hall 4-Stand B47).